Gabapentin Capsule
Product Images NDC 71335-1199

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
This appears to be a chart or graph showing the mean pain score for a study with a 4-week dose titration period and a 4-week fixed dose period. There is a comparison between a placebo group and a group taking 3600 mg/day of Gabapentin. The baseline is also mentioned.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
The text represents a figure in a medical study about patients with postherpetic neuralgia (PHN). The figure shows the proportion of responders (patients with a 50% reduction in pain score) at the endpoint. The percentages range from 10% to 100%, with different values for each study represented in the table below. There are also some values in pounds (GBP), which may indicate costs or doses of medication.*
FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

FDA Label Image

Label (Lbl713351199)

Label (Lbl713351199)
This is a description of Gabapentin Capsules, USP 400 mg with NDC 71335-1199-01. It contains 20 capsules, each of which contains Gabapentin, a drug used to treat seizures and nerve pain caused by herpes virus or shingles (herpes zoster). The users are advised to keep it and all drugs out of the reach of children. It should be stored at 20°C to 25°C (68°F to 77°F), but excursions allowed to 15°C to 30°C (59°F to 86°F) (as per USP controlled Room Temperature). It warns that it might cause dizziness. This drug is only available with a prescription.*
FDA Label Image

Label (Lbl7133511992)

Label (Lbl7133511992)
This appears to be a product label. The label indicates that the package was prepacked by Bryant Ranck. The package can be compared to Neurontin 400mg capsule by Alkem Laboratories Limited. It contains 20 capsules and the expiration date is MM/YY. The NDC number is 7133511991. The storage temperature is between 20°C-25°C (68°F-77°F). The package should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.